WHO ICTRP trial
Double blind placebo controlled study on the efficacy of melatonin on sleep…
NL-OMON30731 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON30731 |
|---|---|
| Public title | Double blind placebo controlled study on the efficacy of melatonin on sleep parameters and quality of life in hemodialysis patients |
| Scientific title | Double blind placebo controlled study on the efficacy of melatonin on sleep parameters and quality of life in hemodialysis patients - Melody |
| Primary sponsor | Meander Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | Dialysis kidney function replacement therapy;10019280;10040998;10038430;Dialysis;kidney function replacement therapy |
| Interventions | melatonin 3 mg once daily (or placebo) ;Heart failure;Melatonin;Quality of life;Sleep |
| Registration date | Aug 27, 2007 |
| Target size | 68 |
| Secondary IDs | 2006-005719-89;aanmelding clinicaltrials.gov;NL12440.100.06 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: